Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Boehringer Ingelheim
Merck
Harvard Business School
McKinsey

Last Updated: February 9, 2023

CLOROTEKAL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Clorotekal, and what generic alternatives are available?

Clorotekal is a drug marketed by B Braun Medical Inc and is included in one NDA. There are two patents protecting this drug.

This drug has thirty-one patent family members in twenty-seven countries.

The generic ingredient in CLOROTEKAL is chloroprocaine hydrochloride. There are four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the chloroprocaine hydrochloride profile page.

Summary for CLOROTEKAL
Drug patent expirations by year for CLOROTEKAL
Drug Prices for CLOROTEKAL

See drug prices for CLOROTEKAL

Recent Clinical Trials for CLOROTEKAL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Oregon Health and Science UniversityPhase 4
B. Braun Medical Inc.Phase 4
University of Alabama at BirminghamPhase 2

See all CLOROTEKAL clinical trials

Pharmacology for CLOROTEKAL
Drug ClassEster Local Anesthetic
Physiological Effect Local Anesthesia

US Patents and Regulatory Information for CLOROTEKAL

CLOROTEKAL is protected by two US patents.

Patents protecting CLOROTEKAL

Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: A METHOD FOR INDUCING A REGIONAL ANAESTHESIA VIA INTRATHECAL ADMINISTRATION OF A PATENTED PRESERVATIVE FREE SOLUTION FOR INJECTION (WITH A SPECIFIC COMPOSITION, PH, OSMOLALITY AND DENSITY) CONTAINING 9-11 MG/ML CHLOROPROCAINE HCL

Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun Medical Inc CLOROTEKAL chloroprocaine hydrochloride SOLUTION;INTRATHECAL 208791-001 Sep 26, 2017 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
B Braun Medical Inc CLOROTEKAL chloroprocaine hydrochloride SOLUTION;INTRATHECAL 208791-001 Sep 26, 2017 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for CLOROTEKAL

See the table below for patents covering CLOROTEKAL around the world.

Country Patent Number Title Estimated Expiration
Serbia 53077 NOVA UPOTREBA ZA KOMPOZICIJU KOJA SADRŽI HLOROPROKAIN HCL, NOVA KOMPOZICIJA KOJA SADRŽI HLOROPROKAIN HCL I POSTUPAK ZA NJENU PROIZVODNJU (NEW USE FOR A COMPOSITION COMPRISING CHLOROPROCAINE HCL, A NEW COMPOSITION COMPRISING CHLOROPROCAINE HCL AND A METHOD FOR ITS MANUFACTURE) See Plans and Pricing
Croatia P20131221 See Plans and Pricing
Philippines 12015501313 CHLOROPROCAINE-BASED PHARMACEUTICAL COMPOSITION FOR REPEATED INTRATHECAL ADMINISTRATION See Plans and Pricing
Cyprus 1114743 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Baxter
Colorcon
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.